《中国保健协会网》
由 中国保健协会保健品市场工作委员会 主办 快速导航  工作邮箱登录
首  页 | 行业聚焦 | 工作动态 | 市场监督 | 非常观点 | 媒体曝光 | 市场峰会 | 庶正康讯
政策法规 | 注册申报 | 批件搜索 | 市场调研 | 调研报告 | 展会信息 | 信用评价 | English 


互联网 www.chca.net.cn
中国保健行业历年十大事件 | 销售商俱乐部 | 《保健食品注册与备案管理办法》7月1日施行 保健食品原料目录(第一批)征求意见

双11冠军上演全球freestyle!Swisse握紧100%分销权

摘编自HH健合集团 2017-11-13  

11月13日,H&H(健合)集团旗下Swisse与PGT达成协议,将全球所有地区的分销权和管理权全部归还Swisse,并且Swisse将回购根据2013年签署的合作协议所授予PGT的分销权,包括中国市场的选择权。在刚刚过去的双11争夺战中,Swisse荣登保健食品/膳食营养补充食品销售指数榜首。据悉,该交易得以使健合真正实现全球化业务。

以下为H&H(健合)集团官微原文——

Swisse Wellness and PGT Healthcare today announced an agreement that will conclude their partnership and return ownership and management of all territories to the Swisse brand globally. The deal will see Swisse buy-back the distribution rights entitled to PGT under the collaboration agreement signed in 2013, including all options on the China market.  

11月13日,Swisse Wellness和PGT Healthcare宣布达成一项协议,包括将结束双方合作伙伴关系,并将全球所有地区的分销权和管理权全部归还Swisse。Swisse将回购根据2013年签署的合作协议所授予PGT的分销权,包括中国市场的选择权。

With Swisse being one of four core brands of the H&H group under the one corporate umbrella, this positions the Group to truly globalize the business and deliver on the ambition to build Swisse as a leading wellness brand worldwide.

Swisse作为H&H(健合)集团旗下四大核心品牌之一,此交易让集团能够真正实现其全球化业务,并实现将Swisse打造成为全球领先的健康品牌的雄心壮志。

With China as the H&H Group’s core market, the company has also been keen to secure the long-term growth of Swisse in this major market and to fully capture the upside of future business and financial return in China.

作为H&H(健合)集团的核心市场,公司致力于确保Swisse在中国的长期增长,并充分把握未来于此市场的业务发展和财务回报的机遇。

Since the beginning of the collaboration between the two organisations, the brand has seen rapid growth in several international markets where PGT has launched Swisse. The success of the Swisse brand model and strong development in Italy, Singapore and Hong Kong, demonstrates the global potential of the brand.

自两家企业开始合作以来,PGT已经在数个国际市场上推出Swisse产品并取得迅速发展。 Swisse品牌的成功与意大利、新加坡和香港等市场的强劲表现证明了该品牌的全球潜力。

PGT has accepted this offer and believes it delivers good value for both parties. In a globalizing market, where eCommerce in particular is changing the face of retail, both PGT and H&H believe their ambitions will be best served via brands that are fully owned. The Swisse brand will have a better future value in the hands of only one owner and the agreement will enable PGT to focus on growing its other brands and businesses.

PGT已经接受了此协议,并认为该协议为双方带来了正面价值。在电子商务正在改变零售业面貌的全球化市场中,PGT和H&H都认为唯有通过全面拥有品牌才能充分达致其未来目标。 在单一品牌所有者的运营下,Swisse将拥有更好的未来价值,而该协议亦将使PGT能够专注于发展其他品牌和业务。

Luo Fei, CEO of H&H Group said, “We are very pleased to have reached this agreement. This empowers us to sustain the development of the Swisse brand in the fast-growing China market and further expand as a premium, proven and aspirational natural health brand globally. It will help us to achieve our vision to become a global leading player in premium nutrition and care, and supports the H&H Group in generating new business opportunities for our four brands in different markets.”

H&H(健合)集团首席执行官罗飞说:“我们很高兴和PGT达成了协议,这使得我们能够在快速增长的中国市场上维持Swisse品牌的发展,并进一步扩展为全球优质、可靠和令人向往的自然健康品牌。此协议更将帮助我们实现成为全球优质营养和护理领域的领先企业的愿景,并支持H&H(健合)集团的四个品牌于不同市场创造新的商机。”

“The arrangement we have had with PGT enabled the Swisse brand to be taken to the world and we are now in a position to drive the business in all markets. We a grateful to PGT for the energy it has put into the brand and to establishing Swisse in valuable European and Asian markets”

“从前我们与PGT的合作协议让Swisse品牌走向世界,为我们于全球市场开展业务创造了条件。我们非常感谢PGT为Swisse品牌所注入的能量,并在宝贵的欧洲和亚洲市场为品牌打下了基础。 “

Briain de Buitleir, CEO – PGT Healthcare said, “Swisse is a very strong brand, which PGT has successfully launched and rapidly developed in several international markets across Europe and Asia. We are proud to have been part of the Swisse global journey and wish good luck to the H&H group to continue to grow the Swisse brand on the international scene”.

PGT Healthcare首席执行官Briain de Buitleir表示:“Swisse是一个非常强大的品牌,PGT已经在欧洲和亚洲的几个国际市场上成功推出Swisse产品并迅速发展。我们很荣幸成为Swisse全球化进程的一部分,并祝愿H&H(健合)集团继续在国际舞台上壮大Swisse品牌。“


摘编自HH健合集团(2017.11.13)

责编|陈白雪





本站转载文章版权属原作者,如有版权疑问请致电010-83505145-212
中国保健协会市场工作委员会 © 2005-2017 版权所有 不得转载 E-mail:xiehui@chca.net.cn 传真:(86)10 83505146
地址:北京右内72号 万博商厦902室 电话:(86)10 83505146(调研业务、信息产品) 83502445(准入咨询) 83504221(协会事务) 83501235(公关事务)
工信部备案号:京ICP备13005185号 北京网聚无限提供网络带宽 公安网监备案号:京公网安备110102006241